Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
0.254
+0.010 (3.92%)
Nov 21, 2024, 1:29 PM EST - Market open

CDIO Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.040.0200-
Revenue Growth (YoY)
180.90%1696.32%5.44%--
Gross Profit
0.040.0200-
Selling, General & Admin
8.387.14.490.570.6
Research & Development
0.030.150.040.030
Operating Expenses
8.437.264.550.620.61
Operating Income
-8.39-7.24-4.55-0.62-0.61
Interest Expense
-0.11-6.74---
Interest & Investment Income
00---
Other Non Operating Income (Expenses)
-0.25.41--0
EBT Excluding Unusual Items
-8.7-8.57-4.55-0.62-0.61
Merger & Restructuring Charges
---0.11--
Other Unusual Items
0.440.19---
Pretax Income
-8.25-8.38-4.66-0.62-0.61
Net Income
-8.25-8.38-4.66-0.62-0.61
Net Income to Common
-8.25-8.38-4.66-0.62-0.61
Shares Outstanding (Basic)
2213311
Shares Outstanding (Diluted)
2213311
Shares Change (YoY)
212.67%310.83%165.44%12.34%-
EPS (Basic)
-0.38-0.66-1.51-0.53-0.58
EPS (Diluted)
-0.38-0.66-1.51-0.53-0.58
Free Cash Flow
-6.03-6.25-5.09-0.590.03
Free Cash Flow Per Share
-0.28-0.49-1.65-0.500.02
Gross Margin
100.00%100.00%100.00%100.00%-
Operating Margin
-23513.43%-42440.43%-478784.32%-68862.15%-
Profit Margin
-23125.63%-49087.81%-490630.00%-68862.15%-
Free Cash Flow Margin
-16909.51%-36612.00%-535891.37%-64960.16%-
EBITDA
-8.14-7.13-4.53-0.6-0.6
D&A For EBITDA
0.250.110.020.020.01
EBIT
-8.39-7.24-4.55-0.62-0.61
Advertising Expenses
-0.160.090.10.01
Source: S&P Capital IQ. Standard template. Financial Sources.